TCL Archive “Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy February 5, 1993
TCL Archive CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule May 9, 1986
TCL Archive FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke. March 18, 2005
TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
